合成生物学风险治理的法律之维——风险审辨与框架构建  

The Legal Dimension of Synthetic Biology Risks Governance——Risks Identification and Framework Construction

作　　者：焦洪涛[1] 李家杭 JIAO Hong-tao;LI Jia-hang(School of Law,Huazhong University of Science and Technology,Wuhan 430070,China)

机构地区：[1]华中科技大学法学院

出　　处：《科技与法律》2019年第5期60-67,共8页Science Technology and Law

基　　金：国家重点研发计划项目“合成生物学伦理、政策法规框架研究”（2018YFA0902400-03）;教育部人文社会科学研究规划基金项目“合成生物学发展中的知识产权问题研究”（19YJA820022）;华中科技大学文科双一流建设项目基金资助

摘　　要：合成生物学是一项颠覆性技术,在风险治理上面临着前所未有的挑战。合成生物学具有"技术形态的科学化"和"技术活动的社会化"的特征,其风险本质上是现代性技术引发的现代性问题,是一种"被制造出来的风险"、后工业社会"不可计算的不安全"和"文明的风险"。与法律相关的合成生物学风险可以从人权、安全、产权解析,并在"三阶观察"的法律治理图式下做出回应,搭建"人权(以伦理评估为前提的伦理法律化)--安全(以体系建构为目标的法律补白)--产权(以问题解决为导向的制度调适)"的法律治理框架。Synthetic biology is a disruptive technology that faces unprecedented challenges in the governance of risk. Synthetic biology has the characteristics of "scientification of technological forms" and "socialization of technical activities".Its risk is essentially the modernity problem caused by modern technology,and it is a kind of "manufactured risk" and "incalculable insecurity" and "civilized risk" in post-industrial society.The risks of synthetic biology related to law can be analyzed from perspectives of human rights,security,and property rights,and give response under the legal governance model of "third-order observation" to build the legal governance framework of "human rights (ethical legalization based on ethical assessment)- Security (filling legal gaps with the aim of system construction)- property rights (problem solving-oriented institutional adaptation )".

关 键 词：合成生物学 风险 治理 法律 框架 

分 类 号：D91[政治法律—法学]